In addition to other updates, new breakpoints have been added for cefiderocol and meropenem-vaborbactam.
ELIZABETH HIRSCH, PHARMD, RPH
Advertisement
Articles by ELIZABETH HIRSCH, PHARMD, RPH
Advertisement
Latest Updated Articles
What's New from the CLSI Subcommittee on Antimicrobial Susceptibility Testing?Published: August 13th 2018 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
CDC ACIP Workgroup Reviewing FDA-Approved HPV Vaccines
2
FDA Clears First At-Home Diagnostic for RSV, Influenza, and COVID-19 in Adults, Young Infants
3
Congress Preserves Domestic HIV Funding in Final FY2026 Spending Deal
4
Reviewing Recently Approved Antibiotics for Uncomplicated Urogenital Gonorrhea
5